IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 73 filers reported holding IRADIMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20,611,507 | +9.9% | 469,083 | +10.0% | 0.00% | – |
Q1 2024 | $18,760,723 | -7.4% | 426,477 | -0.1% | 0.00% | – |
Q4 2023 | $20,263,756 | +10.8% | 426,875 | +3.6% | 0.00% | – |
Q3 2023 | $18,287,140 | -4.5% | 412,151 | +2.7% | 0.00% | – |
Q2 2023 | $19,154,194 | +23.1% | 401,219 | +1.5% | 0.00% | – |
Q1 2023 | $15,559,226 | +43.6% | 395,406 | +3.3% | 0.00% | – |
Q4 2022 | $10,831,420 | -5.8% | 382,871 | +0.1% | 0.00% | – |
Q3 2022 | $11,497,000 | -10.5% | 382,503 | +1.0% | 0.00% | – |
Q2 2022 | $12,851,000 | -15.5% | 378,637 | +11.6% | 0.00% | – |
Q1 2022 | $15,212,000 | +6.3% | 339,257 | +9.6% | 0.00% | – |
Q4 2021 | $14,305,000 | +5.0% | 309,561 | -23.6% | 0.00% | – |
Q3 2021 | $13,619,000 | -5.5% | 405,437 | -17.2% | 0.00% | – |
Q2 2021 | $14,408,000 | +85.1% | 489,913 | +62.2% | 0.00% | – |
Q1 2021 | $7,782,000 | -9.5% | 301,960 | -19.9% | 0.00% | – |
Q4 2020 | $8,596,000 | +15.3% | 377,026 | +8.1% | 0.00% | – |
Q3 2020 | $7,457,000 | -9.2% | 348,793 | -1.5% | 0.00% | – |
Q2 2020 | $8,216,000 | +2.0% | 353,979 | -6.2% | 0.00% | – |
Q1 2020 | $8,054,000 | +20.1% | 377,279 | +31.5% | 0.00% | – |
Q4 2019 | $6,705,000 | +15.1% | 286,803 | +3.5% | 0.00% | – |
Q3 2019 | $5,827,000 | +3.2% | 277,228 | +0.4% | 0.00% | – |
Q2 2019 | $5,649,000 | -25.4% | 276,203 | +2.5% | 0.00% | – |
Q1 2019 | $7,572,000 | +18.1% | 269,545 | +2.8% | 0.00% | – |
Q4 2018 | $6,413,000 | -31.0% | 262,213 | +4.8% | 0.00% | – |
Q3 2018 | $9,298,000 | +114.3% | 250,298 | +19.7% | 0.00% | – |
Q2 2018 | $4,339,000 | +58.2% | 209,114 | +7.5% | 0.00% | – |
Q1 2018 | $2,742,000 | -2.3% | 194,477 | +5.0% | 0.00% | – |
Q4 2017 | $2,806,000 | +66.6% | 185,215 | +5.6% | 0.00% | – |
Q3 2017 | $1,684,000 | +8.4% | 175,425 | -2.9% | 0.00% | – |
Q2 2017 | $1,554,000 | -25.3% | 180,681 | -22.7% | 0.00% | – |
Q1 2017 | $2,081,000 | -8.8% | 233,846 | +13.7% | 0.00% | – |
Q4 2016 | $2,283,000 | -41.9% | 205,647 | -11.1% | 0.00% | – |
Q3 2016 | $3,928,000 | -19.4% | 231,253 | +3.2% | 0.00% | – |
Q2 2016 | $4,876,000 | +22.8% | 224,101 | +8.2% | 0.00% | – |
Q1 2016 | $3,970,000 | +18.9% | 207,213 | +74.0% | 0.00% | – |
Q4 2015 | $3,339,000 | -33.6% | 119,107 | -42.3% | 0.00% | – |
Q3 2015 | $5,028,000 | +783.7% | 206,348 | +743.6% | 0.00% | – |
Q2 2015 | $569,000 | +133.2% | 24,460 | +52.7% | 0.00% | – |
Q1 2015 | $244,000 | +19.0% | 16,020 | +0.6% | 0.00% | – |
Q4 2014 | $205,000 | – | 15,920 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |